Palisade Bio (PALI) Cash from Investing Activities (2010 - 2022)

Palisade Bio (PALI) has 12 years of Cash from Investing Activities data on file, last reported at -$10000.0 in Q4 2022.

• On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$10000.0 in Q4 2022; TTM through Sep 2024 was -$10000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at -$4000.0, up 60.0% from the prior year.
• Cash from Investing Activities for Q4 2022 stood at -$10000.0, up from -$348000.0 in the prior quarter.
• Over the last five years, Cash from Investing Activities for PALI reached as high as $5.0 million in Q1 2018 and fell as low as -$348000.0 in Q3 2021.
• Historically, Cash from Investing Activities has averaged $773381.0 across 4 years, with a median of -$1357.0 in 2018.
• Across the five-year window, Cash from Investing Activities sank 320.1% in 2018 and plunged 34900.0% in 2021, its largest moves.
• Year by year, Cash from Investing Activities stood at -$1714.0 in 2018, then surged by 41.66% to -$1000.0 in 2020, then tumbled by 34700.0% to -$348000.0 in 2021, then jumped by 97.13% to -$10000.0 in 2022.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$10000.0 in Q4 2022, -$348000.0 in Q3 2021, and -$1000.0 in Q4 2020.